OpenAI & CVS Health

OpenAI: OpenAI has restricted the release of its new AI model, GPT-5.6 Sol, at the request of the Trump administration for cybersecurity review, impacting its product rollout and market reach.

CVS Health: CVS Health is facing new state regulations targeting pharmacy benefit managers, which could force the closure of its retail pharmacies in Tennessee, leading to a federal lawsuit and potential business disruption.

OpenAI: OpenAI is a rival to Anthropic in the race to public markets, though Anthropic is currently ahead.

CVS Health: CVS Health climbed after reporting better-than-expected first-quarter results and raising its full-year financial forecasts.

OpenAI: Microsoft's partnership with OpenAI is mentioned as having grown tangled, suggesting Project Solara is a way for Microsoft to establish its own distinct AI narrative and platform.

CVS Health: CVS Health is an early pilot partner for Project Solara, indicating potential applications of AI agent-first devices in the healthcare sector, such as patient care and note-taking.